EHA 2022: ATLAS Highlights Benefits of Carfilzomib-Lenalidomide-Dexamethasone Maintenance Over Lenalidomide Alone in Multiple Myeloma
Findings suggest this combination should be considered as a new standard of care in select patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.